Deutsche Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.18M | Sell |
389,847
-540,355
| -58% | -$13.8M | ﹤0.01% | 1080 |
|
|
2025
Q4 | $27M | Buy |
930,202
+552,674
| +146% | +$14.1M | 0.01% | 800 |
|
|
2025
Q3 | $7.12M | Buy |
377,528
+10,113
| +3% | +$159K | ﹤0.01% | 1163 |
|
|
2025
Q2 | $5.15M | Sell |
367,415
-13,940
| -4% | -$195K | ﹤0.01% | 1225 |
|
|
2025
Q1 | $5.96M | Sell |
381,355
-6,181
| -2% | -$87.1K | ﹤0.01% | 1183 |
|
|
2024
Q4 | $5.4M | Sell |
387,536
-412,491
| -52% | -$4.52M | ﹤0.01% | 1296 |
|
|
2024
Q3 | $7.44M | Sell |
800,027
-1,081,998
| -57% | -$10.7M | ﹤0.01% | 1120 |
|
|
2024
Q2 | $17.5M | Buy |
1,882,025
+9,420
| +0.5% | +$85.2K | 0.01% | 849 |
|
|
2024
Q1 | $18.6M | Buy |
1,872,605
+478,195
| +34% | +$3.57M | 0.01% | 835 |
|
|
2023
Q4 | $4.5M | Buy |
1,394,410
+1,364,048
| +4,493% | +$3.71M | ﹤0.01% | 1295 |
|
|
2023
Q3 | $161K | Buy |
30,362
+3,655
| +14% | +$31.1K | ﹤0.01% | 2918 |
|
|
2023
Q2 | $255K | Sell |
26,707
-9,586
| -26% | -$106K | ﹤0.01% | 2750 |
|
|
2023
Q1 | $399K | Buy |
36,293
+11,121
| +44% | +$161K | ﹤0.01% | 2623 |
|
|
2022
Q4 | $373K | Buy |
25,172
+6,968
| +38% | +$122K | ﹤0.01% | 2602 |
|
|
2022
Q3 | $348K | Buy |
18,204
+555
| +3% | +$12.6K | ﹤0.01% | 2605 |
|
|
2022
Q2 | $376K | Buy |
17,649
+2,458
| +16% | +$50.4K | ﹤0.01% | 2769 |
|
|
2022
Q1 | $293K | Sell |
15,191
-1,778
| -10% | -$30.1K | ﹤0.01% | 3051 |
|
|
2021
Q4 | $352K | Buy |
16,969
+882
| +5% | +$17.6K | ﹤0.01% | 3044 |
|
|
2021
Q3 | $384K | Sell |
16,087
-1,946
| -11% | -$44.4K | ﹤0.01% | 3203 |
|
|
2021
Q2 | $492K | Buy |
18,033
+1,428
| +9% | +$40.2K | ﹤0.01% | 3228 |
|
|
2021
Q1 | $480K | Sell |
16,605
-99,330
| -86% | -$3.1M | ﹤0.01% | 3130 |
|
|
2020
Q4 | $3.26M | Buy |
115,935
+106,120
| +1,081% | +$2.6M | ﹤0.01% | 1603 |
|
|
2020
Q3 | $288K | Buy |
9,815
+5,090
| +108% | +$136K | ﹤0.01% | 2990 |
|
|
2020
Q2 | $143K | Buy |
4,725
+1,067
| +29% | +$30.8K | ﹤0.01% | 3285 |
|
|
2020
Q1 | $109K | Buy |
+3,658
| New | +$98.3K | ﹤0.01% | 3207 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
